38608-07-0

Basic information

• Product Name: 1,2-DIAMINO-4,5-METHYLENEDIOXYBENZENE, DIHYDROCHLORIDE
• Synonyms: 4,5-Methylenedioxy-1,2-phenylenediamine;Benzodioxole-5,6-diamine;1,3-Benzodioxole-5,6-diamine,tech
• CAS NO: 38608-07-0
• Molecular Formula: C₇H₈N₂O₂
• Molecular Weight: 225.07
• Mol File: 38608-07-0.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 352℃
• Flash Point: 205℃
• Appearance: /
• Density: 1.446
• Vapor Pressure: 3.88E-05mmHg at 25°C
• Refractive Index: 1.705
• CAS DataBase Reference: 1,2-DIAMINO-4,5-METHYLENEDIOXYBENZENE, DIHYDROCHLORIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2-DIAMINO-4,5-METHYLENEDIOXYBENZENE, DIHYDROCHLORIDE(38608-07-0)
• EPA Substance Registry System: 1,2-DIAMINO-4,5-METHYLENEDIOXYBENZENE, DIHYDROCHLORIDE(38608-07-0)

Safety Data

• Hazardous Substances Data: 38608-07-0(Hazardous Substances Data)

Usage

General Description

1,2-Diamino-4,5-methylenedioxybenzene, dihydrochloride is a chemical compound with two amino groups and a methylenedioxybenzene structure. It is commonly used in the development of novel drugs and pharmaceuticals due to its potential to effectively interact with biological systems. 1,2-DIAMINO-4,5-METHYLENEDIOXYBENZENE, DIHYDROCHLORIDE has been found to have strong antioxidant and anti-inflammatory properties, making it valuable in the medical field for the treatment of various diseases and conditions. Additionally, it has been studied for its potential use in the synthesis of dyes and as a component in materials science. Overall, 1,2-Diamino-4,5-methylenedioxybenzene, dihydrochloride is a versatile chemical with a wide range of potential applications in various industries.

InChI:InChI=1/C7H8N2O2/c8-4-1-6-7(2-5(4)9)11-3-10-6/h1-2H,3,8-9H2

Upstream product

• 2620-44-2 5-nitro-1,3-benzodioxole 
• 274-09-9 Methylenedioxybenzene 
• 7748-59-6 5,6-dinitro-benzo[1,3]dioxole 
• 102-51-2 4-methoxy-1,2-phenylenediamine 

Downstream Products

• 35541-25-4 2-Mercapto-5,6-methylendioxy-benzimidazol 

Relevant articles and documents

HETEROCYCLIC LSF INHIBITORS AND THEIR USES

The present invention is directed to heterocyclic SV40 Factor (LSF) inhibitors and their uses. In some implementations, the present invention discloses small-molecule compounds of Formula (I). In some implementations, the compounds of Formula (I) are used

Benzimidazole compound

An object of the present invention is to provide a novel chemical compound useful as a therapeutic or prophylactic agent for acid-related diseases, having an excellent inhibitory effect against gastric acid secretion, an excellent effect of maintaining the inhibitory effect against gastric acid secretion, thereby maintaining intragastric pH high for a long time, and having more safety and appropriate physicochemical stability. Provided is a compound represented by where R1 and R3 may be the same or different and each represent a hydrogen atom or a C1-C6 alkyl group; R2 represents (5,5-dimethyl-1,3-dioxan-2-yl)methoxy group, 5,7-dioxaspiro[2.5]oct-6-ylmethoxy group, 1,5,9-trioxaspiro[5.5]undec-3-ylmethoxy group, or (2,2-dimethyl-1,3-dioxan-5-yl)methoxy group; R4, R5, R6 and R7 represent a hydrogen atom, halogen atom, C1-C6 alkyl group, C1-C6 haloalkyl group, C1-C6 alkoxy group or C1-C6 haloalkoxy group; and W1 represents a single bond, methylene or ethylene group, a salt thereof or a solvate of these.

Structure-activity relationships of alkyl- and alkoxy-substituted 1,4- dihydroquinoxaline-2,3-diones: Potent and systemically active antagonists for the glycine site of the NMDA receptor

We report on a series of alkyl- and alkoxy-substituted 1,4- dihydroquinoxaline-2,3-diones (QXs), prepared as a continuation of our structure-activity relationship (SAR) study of QXs as antagonists for the glycine site of the N-methyl-D-aspartate (NMDA) re